Liquidia Corp
LQDA
96 insider filings · Latest: Oct 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 13 8:30 PM | Stephen M BlochDirector | Sale | 318,893 | $50.23 | $16.0M | 1,870,042(I) | View → |
| May 12, 2026 | May 12 10:52 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $54.04 | $1.4M | 1,273,095(I) | View → |
| May 11, 2026 | May 12 10:52 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $41.50 | $1.0M | 1,298,095(I) | View → |
| May 8, 2026 | May 12 10:52 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $42.14 | $1.1M | 1,323,095(I) | View → |
| May 11, 2026 | May 11 9:52 PM | Canaan VIII LP | Proposed Sale | 318,893 | $49.86 | $15.9M | — | View → |
| May 8, 2026 | May 8 8:19 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 100,000 | $42.28 | $4.2M | — | View → |
| May 7, 2026 | May 7 10:19 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $42.09 | $1.1M | 1,348,095(I) | View → |
| May 6, 2026 | May 7 10:19 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.78 | $1.0M | 1,373,095(I) | View → |
| May 5, 2026 | May 7 10:19 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.10 | $1.0M | 1,398,095(I) | View → |
| May 7, 2026 | May 7 8:18 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 25,000 | $42.14 | $1.1M | — | View → |
| Apr 27, 2026 | Apr 29 8:31 PM | Dana BoyleChief Accounting Officer | Sale | 1,576 | $37.78 | $59.5K | 175,342(D) | View → |
| Apr 27, 2026 | Apr 29 8:30 PM | Jason AdairChief Business Officer | Sale | 688 | $41.65 | $28.7K | 214,738(D) | View → |
| Apr 17, 2026 | Apr 21 8:30 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 18,839 | $40.60 | $765.0K | 1,423,095(I) | View → |
| Apr 17, 2026 | Apr 17 8:39 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 68,839 | $41.40 | $2.8M | — | View → |
| Apr 16, 2026 | Apr 17 12:38 AM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.31 | $1.0M | 1,441,934(I) | View → |
| Apr 15, 2026 | Apr 17 12:38 AM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.14 | $1.0M | 1,466,934(I) | View → |
| Apr 14, 2026 | Apr 17 12:38 AM | Roger JeffsDirector, Chief Executive Officer | Sale | 3,300 | $40.00 | $132.0K | 1,491,934(I) | View → |
| Apr 15, 2026 | Apr 17 12:37 AM | Michael KasetaCFO and COO | Sale | 139,390 | $40.14 | $5.6M | 353,356(D) | View → |
| Apr 14, 2026 | Apr 17 12:37 AM | Michael KasetaCFO and COO | Sale | 3,000 | $40.00 | $120.0K | 405,775(D) | View → |
| Apr 16, 2026 | Apr 16 8:13 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 25,000 | $40.12 | $1.0M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Mar 3 9:30 PM | Jason AdairChief Business Officer | Option Exercise | 1,562 | — | 0(D) | View → |
| Jan 16, 2026 | Jan 21 11:28 PM | Jason AdairChief Business Officer | Grant/Award | 41,525 | — | 41,525(D) | View → |
| Jan 16, 2026 | Jan 21 11:27 PM | Dana BoyleChief Accounting Officer | Grant/Award | 35,592 | — | 35,592(D) | View → |
| Jan 16, 2026 | Jan 21 11:24 PM | Roger JeffsDirector, Chief Executive Officer | Grant/Award | 173,016 | — | 173,016(D) | View → |
| Jan 16, 2026 | Jan 21 11:23 PM | Michael KasetaCFO and COO | Grant/Award | 88,980 | — | 88,980(D) | View → |
| Jan 16, 2026 | Jan 21 11:20 PM | Sarah KreppChief Human Resource Officer | Grant/Award | 35,592 | — | 35,592(D) | View → |
| Jan 16, 2026 | Jan 21 11:18 PM | Scott MoomawChief Commercial Officer | Grant/Award | 49,433 | — | 49,433(D) | View → |
| Jan 16, 2026 | Jan 21 11:16 PM | Rajeev SaggarChief Medical Officer | Grant/Award | 49,433 | — | 49,433(D) | View → |
| Jan 16, 2026 | Jan 21 11:16 PM | Russell SchundlerGeneral Counsel | Grant/Award | 49,433 | — | 49,433(D) | View → |
← Previous
Page 3 of 3